Axsome Therapeutics (AXSM) announced it is recognizing Mental Illness Awareness Week, MIAW, alongside the national mental health advocacy community including the National Alliance on Mental Illness, NAMI. “Mental health matters every day. But during MIAW, we come together to raise awareness, support one another, and build stronger communities. NAMI is dedicated to providing advocacy, education, support, and public awareness so that all individuals and families affected by mental illness can build better lives,” said Jessica Edwards, NAMI’s Chief Development Officer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXSM:
- Axsome Therapeutics initiated with a Buy at B. Riley
- Axsome Therapeutics: Strong Growth Trajectory and Financial Outlook Justify Buy Rating
- RBC lists biotech winners should RFK depart HHS
- RBC lists biotech winners should RFK departure HHS
- Axsome Therapeutics assumed with an Overweight at Wells Fargo